Diabetes Management Stocks List

Diabetes Management Stocks Recent News

Date Stock Title
May 3 TNDM Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday
May 3 TNDM Q1 2024 Tandem Diabetes Care Inc Earnings Call
May 3 TNDM Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
May 3 TNDM Tandem Diabetes Care, Inc. (TNDM) Q1 2024 Earnings Call Transcript
May 2 TNDM Tandem Diabetes Care (TNDM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 2 PODD Insulet (PODD) Rises Higher Than Market: Key Facts
May 2 TNDM Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings: Outperforms Revenue Estimates and Updates ...
May 2 TNDM Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
May 2 TNDM Tandem Diabetes Care GAAP EPS of -$0.65 beats by $0.12, revenue of $191.67M beats by $18.13M
May 2 TNDM Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
May 2 PODD Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
May 2 GCTK GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
May 1 TNDM Tandem Diabetes Care Q1 2024 Earnings Preview
Apr 29 TNDM Tandem Diabetes Care Announces Upcoming Conference Presentations
Apr 29 TNDM Are Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?
Apr 29 TNDM Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Apr 29 PODD DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo
Apr 29 TNDM DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo
Apr 28 PODD American Politicians are Selling These 10 Stocks
Apr 26 PODD Insulet (PODD) Outperforms Broader Market: What You Need to Know
Diabetes Management

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentration of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance. The pancreas of a person with type 2 diabetes may be producing normal or even abnormally large amounts of insulin. Other forms of diabetes mellitus, such as the various forms of maturity onset diabetes of the young, may represent some combination of insufficient insulin production and insulin resistance. Some degree of insulin resistance may also be present in a person with type 1 diabetes.
The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Other goals of diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment.

Browse All Tags